XML 12 R5.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Stockholders' Equity (Deficiency) (Unaudited) - USD ($)
Common Stock [Member]
Retained Earnings [Member]
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
Total
Balance (in shares) at Dec. 31, 2017 65,169,703      
Balance at Dec. 31, 2017 $ 23,133,400 $ (23,305,389) $ 24,580 $ (147,409)
Private placement (in shares) 7,290,000      
Private placement $ 2,551,500     2,551,500
Share issuance costs (271,358)     (271,358)
Stock-based compensation 3,693     3,693
Net loss and comprehensive loss (835,368) (835,368)
Exercise of Warrants (in shares) 15,000      
Exercise of Warrants $ 6,600 6,600
Balance (in shares) at Mar. 31, 2018 72,474,703      
Balance at Mar. 31, 2018 $ 25,423,835 (24,140,757) 24,580 1,307,658
Balance (in shares) at Dec. 31, 2018 73,674,703      
Balance at Dec. 31, 2018 $ 26,552,468 (25,898,220) 24,580 678,828
Acquisition of subsidiary (in shares) 52,450,286      
Acquisition of subsidiary $ 20,603,655 20,603,655
Private placement (in shares) 5,000,000      
Private placement $ 2,000,000     2,000,000
Share issuance costs (236,800)     (236,800)
Stock-based compensation 4,980     4,980
Net loss and comprehensive loss (826,304) (826,304)
Balance (in shares) at Mar. 31, 2019 131,124,989      
Balance at Mar. 31, 2019 $ 48,924,303 $ (26,724,524) $ 24,580 $ 22,224,359